Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
aidenb's Profile
Displaying 1-50 of 526 result(s).
CYDY CytoDyn Inc
10/04/2021 1:19:58 PM
Quote : CEO? I would imagine there (2)
CYDY CytoDyn Inc
09/30/2021 12:09:53 PM
Craig . Are there any better option (1)
CYDY CytoDyn Inc
09/29/2021 11:08:57 PM
We go for debt financing when we kn (11)
CYDY CytoDyn Inc
09/29/2021 5:06:33 PM
Paul R. Thanked Nader and mentioned (4)
CYDY CytoDyn Inc
09/29/2021 8:06:10 AM
Quote: no history of raising money. (8)
CYDY CytoDyn Inc
09/29/2021 6:30:30 AM
The Activist Group’s Continued At (5)
CYDY CytoDyn Inc
09/28/2021 10:56:41 PM
Quote: If only one print went throu
CYDY CytoDyn Inc
09/25/2021 4:05:54 PM
Quote: Dr. Yo is still working with (2)
CYDY CytoDyn Inc
09/25/2021 1:22:47 PM
Are you a litigation lawyer? Those (13)
CYDY CytoDyn Inc
09/22/2021 1:33:33 AM
If Patterson gets a exec job in thi (13)
CYDY CytoDyn Inc
09/21/2021 4:59:28 PM
I agree. We didn't get the Brazil n
CYDY CytoDyn Inc
09/20/2021 7:57:28 PM
I posted Yo's liquidation on Stockt (3)
CYDY CytoDyn Inc
09/18/2021 12:18:15 AM
Quote: . welcome back to $2! That d (2)
CYDY CytoDyn Inc
09/16/2021 3:43:37 PM
Quote l: That you really think they (2)
CYDY CytoDyn Inc
09/15/2021 8:24:28 PM
Nader spilled the beans, again. Oth (2)
CYDY CytoDyn Inc
09/07/2021 11:05:51 AM
Is Dr. Recknor on BOD? If he is the (1)
CYDY CytoDyn Inc
09/07/2021 10:46:06 AM
I like it that Dr. Recknor is inves
CYDY CytoDyn Inc
09/07/2021 10:29:59 AM
You are correct. As stated many tim (5)
CYDY CytoDyn Inc
09/06/2021 11:39:19 PM
Bruce did show the email his offer (2)
CYDY CytoDyn Inc
08/31/2021 8:18:58 PM
Quote: I am waiting for the next in (3)
CYDY CytoDyn Inc
08/28/2021 1:27:56 PM
Skys are falling! Run! I just sold (2)
CYDY CytoDyn Inc
08/25/2021 6:20:33 PM
I'd expect BB and Point72 and other (1)
CYDY CytoDyn Inc
08/25/2021 5:19:55 PM
Quote l: Our shares. Basic question (2)
CYDY CytoDyn Inc
08/07/2021 5:48:37 AM
Fantastic DD on Merck potential con
CYDY CytoDyn Inc
08/06/2021 9:52:39 PM
Everyone gets over the divorce soon (3)
CYDY CytoDyn Inc
08/05/2021 5:17:34 PM
I'll look into the case, but I'd as
CYDY CytoDyn Inc
08/05/2021 4:56:21 PM
Thank you Ken. I'm glad you pointed (2)
CYDY CytoDyn Inc
08/05/2021 3:59:05 PM
Based on my experience in similar s (2)
CYDY CytoDyn Inc
08/05/2021 2:40:44 PM
No. But I'm looking forward a new l (8)
CYDY CytoDyn Inc
08/04/2021 5:14:42 PM
...to be precise... It's hard to c (3)
CYDY CytoDyn Inc
08/04/2021 4:06:38 PM
You wish.
CYDY CytoDyn Inc
07/13/2021 3:52:38 PM
CYDY is super attractive now. Once (9)
CYDY CytoDyn Inc
04/29/2021 5:07:08 PM
Quote : CYDY is up over 600% over t
CYDY CytoDyn Inc
04/07/2021 6:53:34 PM
I was never enthusiastic about him (4)
CYDY CytoDyn Inc
04/07/2021 6:44:07 PM
Good news. 100k Philippines vial ca (4)
CYDY CytoDyn Inc
04/07/2021 6:19:52 PM
Mahboob was fired. That's why the C (3)
CYDY CytoDyn Inc
03/19/2021 12:48:22 AM
There was 2 reasons for Monday upda
CYDY CytoDyn Inc
03/09/2021 6:13:41 PM
First time in over a year buying my (1)
CYDY CytoDyn Inc
03/09/2021 1:37:25 AM
We already have a winner here, yet (1)
CYDY CytoDyn Inc
12/18/2020 9:26:12 AM
Quote: The trial was powered to ach
CYDY CytoDyn Inc
12/16/2020 11:48:36 AM
Now that full enrollment is done.,
CYDY CytoDyn Inc
12/13/2020 12:38:24 AM
Quote Vyrologix(Leronlimab) will be
CYDY CytoDyn Inc
12/12/2020 8:36:46 PM
Ganesha pointed out that the math d
CYDY CytoDyn Inc
12/12/2020 10:52:05 AM
Quote: IncellDx to launch Leronlima (2)
CYDY CytoDyn Inc
11/23/2020 3:01:14 PM
Nader is giving up on the US FDA He (3)
CYDY CytoDyn Inc
11/17/2020 1:32:45 PM
I see bashers here. Just to set thi (10)
CYDY CytoDyn Inc
11/17/2020 12:48:55 AM
It's a typo in their 8k filing. It (2)
CYDY CytoDyn Inc
11/11/2020 4:06:00 PM
BTW. That's the new house in the ba (1)
CYDY CytoDyn Inc
11/11/2020 3:19:01 PM
He said dividend and share buyback. (2)
CYDY CytoDyn Inc
11/11/2020 9:36:14 AM
Moving towards the 293 mark in 2 we (8)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Prairie Provident Resources Highlights AGM Success and Future Plans
  • Understanding Distribution Sources for Cohen & Steers RQI Fund
  • Cohen & Steers Fund Distribution Sources and Performance Insights
  • KBR and ACMI Properties Unite for Spaceflight Food Innovation
  • Heritage Commerce Corp's Board Leadership Transition Unveiled
  • Maxus Mining Expands Options and Continues Growth in Exploration
  • Exciting New Drill Results at Mount Polley by Imperial Metals
  • Ibotta Inc. Securities Lawsuit Offers Chance for Investors
  • Iovance Biotherapeutics Faces Class Action Lawsuit from Investors
  • Pivot Bio's Strategic Relocation to Transform AgTech Landscape
  • Bantam Pharmaceutical's Innovation at ASCO 2025: BTM-3566
  • Understanding Distribution Sources of Cohen & Steers Fund
  • Silver Star Properties Navigates Legal Challenges and Strategy Update
  • Celebrating Excellence in the Building Industry: Awards 2025
  • BOXABL Embraces Bitcoin Strategy for Treasury Reserves
  • Johnson & Johnson's IMAAVY Hits Myasthenia Gravis Market
  • Cohen & Steers Total Return Realty Fund Updates for Investors
  • SFC Enhances Community Engagement with New Ice Rink Management
  • Boehringer Ingelheim Unveils Promising Cancer Trials at ASCO 2025
  • Soleno Therapeutics Advances in Treating Hyperphagia for PWS
  • Embracing Peace Through Collective Prayer and Support
  • Understanding Distribution Sources for Cohen & Steers' Fund
  • Innovative Cancer Research from RWJBarnabas Health Surfaces
  • Abeona's ZEVASKYN Breakthrough: A New Hope for DEB Patients
  • Silvercorp Exhibits Strong Fiscal Year-End Performance 2025
  • Univest Securities Completes $5 Million Offering for WORK Medical Tech
  • Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
  • Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
  • Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
  • Daktronics Engages at Leading Investor Conference This May
  • Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
  • IMUNON Seeks to Withdraw Registration Amid Growth Plans
  • Abcourt Mines Inc. Reports Solid Third Quarter Progress
  • PDS Biotech Shares Positive Results for Versamune® HPV Treatments
  • Servotronics' Proxy Contest Conclusion and Upcoming Meeting
  • Haivision to Unveil Financial Insights for Q2 Fiscal 2025
  • M-tron Industries, Inc. Announces Upcoming Investor Meeting
  • Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
  • Investors Can Join Digimarc Corporation Class Action Today
  • ImCheck Therapeutics Showcases Promising AML Therapy Results
  • Legend Biotech Reveals Significant Updates in Cancer Treatment
  • ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
  • Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
  • Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
  • Acceleware Ltd. Achieves Significant Progress in Q1 2025
  • Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
  • Petrus Resources Shares Success of Annual Meeting Outcomes
  • Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
  • Candel Therapeutics Advances Localized Prostate Cancer Treatment
  • Adagene Showcases Promising Results for ADG126 in Cancer Trials
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site